Brain stimulation for depression-associated symptoms – a real-world clinical investigation of noninvasive brain stimulation treatments offered at the Department of Psychiatry and Psychotherapy of the LMU Hospital

Department of Psychiatry and Psychotherapy, LMU Hospital Munich0 个研究点目标入组 1,300 人开始时间: 2022年4月28日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Indication for NTBS treatment for a depressive episode as assessed by the clinical evaluation
•- Patient preference for NTBS treatment
•- Capable and willing to provide informed consent.

•- Individuals with a substance abuse disorder or substance dependence (except nicotine, caffeine) in the last 6 months
•- Individuals at suicidal risk
•- Any relevant instable medical condition (e.g. acute, unstable cardiac disease)
•- Individuals diagnosed with a significant neurological disorder or insult including, but not limited to:
•oIncreased intracranial pressure
•oSpace occupying brain lesion
•oHistory of cerebrovascular accident
•oTransient ischemic attack within two years
•oCerebral aneurysm
•oHuntington’s chorea
•oMultiple sclerosis
•- Individuals with a history of severe traumatic brain injury or status post brain/heart surgery
•- In general, individuals with any history of seizures
•- Individuals with significant anatomical abnormalities as seen on cerebral MRI
•- Individuals with non-removable, ferromagnetic implants/material in proximity to application site (e.g. cochlear implant, implanted neurostimulators, nails, clips, etc.) or treatment-relevant ferromagnetic implants in other body parts (e.g. cardiac pacemaker)
•- For tDCS specifically – severe skin disorders (e.g. psoriasis vulgaris) in proximity to application site

发起方

Department of Psychiatry and Psychotherapy, LMU Hospital Munich